Näytä suppeat kuvailutiedot

dc.contributor.authorJohansson, Edvard
dc.contributor.authorKallionpää, Roope A.
dc.contributor.authorBöckerman, Petri
dc.contributor.authorPeltonen, Juha
dc.contributor.authorPeltonen, Sirkku
dc.date.accessioned2021-01-21T14:57:45Z
dc.date.available2021-01-21T14:57:45Z
dc.date.issued2021
dc.identifier.citationJohansson, E., Kallionpää, R. A., Böckerman, P., Peltonen, J., & Peltonen, S. (2021). A rare disease and education : Neurofibromatosis type 1 decreases educational attainment. <i>Clinical Genetics</i>, <i>99</i>(4), 529-539. <a href="https://doi.org/10.1111/cge.13907" target="_blank">https://doi.org/10.1111/cge.13907</a>
dc.identifier.otherCONVID_47643404
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/73754
dc.description.abstractRare heritable syndromes may affect educational attainment. Here, we study education in neurofibromatosis 1 (NF1) that is associated with multifaceted medical, social and cognitive consequences. Educational attainment in the Finnish population‐based cohort of 1408 individuals with verified NF1 was compared with matched controls using Cox proportional hazards model with delayed entry and competing risk for death. Moreover, models accounting for the effects of cancer at age 15–30 years, parental NF1 and developmental disorders were constructed. Overall, the attainment of secondary education was reduced in individuals with NF1 compared to controls (hazard ratio 0.83, 95%CI 0.74–0.92). History of cancer and developmental disorders were major predictors of lack of secondary education. Individuals with NF1 obtained vocational secondary education more often than general upper secondary education. Consequently, NF1 decreased the attainment of Bachelor's and Master's degrees by 46–49% and 64–74%, respectively. Surprisingly, the non‐NF1 siblings of individuals with NF1 also had lower educational attainment than controls, irrespective of parental NF1. In conclusion, NF1 is associated with reduced educational attainment and tendency for affected individuals to obtain vocational instead of academic education. Individuals living with NF1, especially those with cancer, developmental disorders or familial NF1, need effective student counselling and learning assistance.en
dc.format.mimetypeapplication/pdf
dc.languageeng
dc.language.isoeng
dc.publisherWiley-Blackwell
dc.relation.ispartofseriesClinical Genetics
dc.rightsCC BY-NC-ND 4.0
dc.subject.othereducational attainment
dc.subject.othermultiorgan syndrome
dc.subject.otherneurofibromatosis 1
dc.subject.otherrare disease
dc.subject.otherschool performance
dc.titleA rare disease and education : Neurofibromatosis type 1 decreases educational attainment
dc.typeresearch article
dc.identifier.urnURN:NBN:fi:jyu-202101211219
dc.contributor.laitosKauppakorkeakoulufi
dc.contributor.laitosSchool of Business and Economicsen
dc.contributor.oppiaineTaloustiedefi
dc.contributor.oppiaineEmpirical Microeconomicsfi
dc.contributor.oppiainePäätöksentekoa tukeva taloustiede ja talouden kilpailukyky (painoala)fi
dc.contributor.oppiaineBasic or discovery scholarshipfi
dc.contributor.oppiaineEconomicsen
dc.contributor.oppiaineEmpirical Microeconomicsen
dc.contributor.oppiainePolicy-Relevant Economics and Competitiveness of Economy (focus area)en
dc.contributor.oppiaineBasic or discovery scholarshipen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.format.pagerange529-539
dc.relation.issn0009-9163
dc.relation.numberinseries4
dc.relation.volume99
dc.type.versionpublishedVersion
dc.rights.copyright© 2020 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.
dc.rights.accesslevelopenAccessfi
dc.type.publicationarticle
dc.subject.ysoperinnölliset taudit
dc.subject.ysoharvinaiset taudit
dc.subject.ysoneurofibromatoosi
dc.subject.ysokoulutustaso
dc.subject.ysoopintomenestys
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p19997
jyx.subject.urihttp://www.yso.fi/onto/yso/p25145
jyx.subject.urihttp://www.yso.fi/onto/yso/p6082
jyx.subject.urihttp://www.yso.fi/onto/yso/p12157
jyx.subject.urihttp://www.yso.fi/onto/yso/p8586
dc.rights.urlhttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.relation.doi10.1111/cge.13907
jyx.fundinginformationThe study was funded with grants from the Finnish Cancer Foundation and Turku University Hospital. This work is generated within the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS)—Project ID No 739547. ERN GENTURIS is partly co-funded by the European Union within the framework of the Third Health Programme “ERN-2016-Framework Partnership Agreement 2017-2021”.
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY-NC-ND 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY-NC-ND 4.0